Skip to main content
. 2015 Jun 15;128(11):1251.e11–1251.e20. doi: 10.1016/j.amjmed.2015.05.034

Table 1.

Demographics, Medical History, and Smoking History of the 2 Patient Groups

Group 1 (N = 100) Group 2 (N = 101)
Demographics
 Age (y), Mean ± SD 66.6 ± 20.3 30.6 ± 6.4
 Gender, No. (%)
 Male 90 (90.0) 44 (43.6)
 Female 10 (10.0) 57 (56.4)
Race (and ethnicity), No. (%)
 Black/African 28 (28.0) 29 (28.7)
 Hispanic/Latino 0 1 (1.0)
 Asian 0 3 (3.0)
 White 71 (71.0) 64 (63.3)
 Hispanic/Latino 0 2 (2.0)
 Unknown (and Hispanic/Latino) 1 (1.0) 2 (2.0)
CLDSI, baseline value, Mean ± SD 14.4 ± 4.2 NA
Medical History
 Renal/kidney/bladder disease, No. (%) 33 (33.7) 1 (1.0)
 Heart disease: Yes; No. (%) 76 (77.6) 0
 Congestive heart disease 17 (17.4) 0
 Ischemic/coronary artery disease 62 (63.3) 0
 Valvular disease 15 (15.3) 0
 Other heart disease 12 (12.2) 0
 Liver disease, No. (%) 10 (10.2) 1 (1.0)
 Blood disease, No. (%) 0 1 (1.0)
 Lung disease: Yes; No. (%) 64 (65.3) 0
 Chronic obstructive pulmonary disease 37 (37.8) 0
 Chronic bronchitis 17 (17.4) 0
 Emphysema 10 (10.2) 0
 Asthma 16 (16.3) 0
 Other lung disease 10 (10.3) 0
 Neurologic disease, No. (%) 38 (38.8) 7 (7.0)
 Diabetes mellitus, No. (%) 33 (33.7) 0
 Cancer: Yes, No. (%) 26 (26.5) 1 (1.0)
 Seasonal rhinitis, eg, hay fever: No. (%) 60 (61.9) 45 (44.6)
 Otitis or sinusitis, No. (%) 23 (24.0) 21 (20.8)
Smoking History
 Current cigarette smoker, No. (%) 16 (16.5) 19 (18.8)
 Ever smoked cigarettes, No. (%) 70 (72.9)§ 31 (30.7)§

Group 1 patients were at least 60 years of age with underlying chronic lung or heart disease. Group 2 patients were healthy and aged 18-40 years. Group 2 patients could not have a medical history of underlying heart and lung disease. Comparisons of categoric variables by chi-square tests. Characteristics did not differ between male and female patients in group 2 (data not shown).

CLDSI = Chronic Lung Disease Severity Index; NA = not available; SD = standard deviation.

P < .0001, greater proportion of male patients in group 1 than group 2.

The CLDSI score was determined only in group 1 patients.

Patients with underlying lung disease could have >1 pulmonary diagnosis based on reported history and medical record review.

§

P < .0001, greater proportion of patients who ever smoked cigarettes in group 1 than in group 2.